ABCA1: ATP-binding cassette transporter A1
When this happens, you may experience digestive discomfort, weight loss plateaus, or temporary setbacksbut these events offer valuable feedback about your individual response to the medication
Eligible patients may discuss Tirzepatide during a consultation
The FDA label specifically warns about hypersensitivity reactions, including anaphylaxis and angioedema
Although the results are promising, they highlight the need for further research to validate these associations and understand the underlying mechanisms, writes Qeadan in his research report published in Addiction
References Frohman LA, Downs TR, Chomczynski P